Lisata Therapeutics, Inc.LSTANASDAQ
Loading
Year-over-year book value per share growth
Latest
-14.21%
↓ 126% vs avg
Percentile
P41
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
53.78%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -14.21% |
| Q3 2025 | -18.85% |
| Q2 2025 | -17.27% |
| Q1 2025 | -17.09% |
| Q4 2024 | -12.40% |
| Q3 2024 | -12.14% |
| Q2 2024 | -11.26% |
| Q1 2024 | -12.41% |
| Q4 2023 | -9.12% |
| Q3 2023 | -10.03% |
| Q2 2023 | -5.33% |
| Q1 2023 | -43.12% |
| Q4 2022 | -11.62% |
| Q3 2022 | -25.73% |
| Q2 2022 | -6.87% |
| Q1 2022 | -5.32% |
| Q4 2021 | -6.77% |
| Q3 2021 | -6.15% |
| Q2 2021 | -32.65% |
| Q1 2021 | 133.13% |
| Q4 2020 | -44.41% |
| Q3 2020 | -21.01% |
| Q2 2020 | 59.59% |
| Q1 2020 | -18.52% |
| Q4 2019 | -18.22% |
| Q3 2019 | -15.81% |
| Q2 2019 | -17.06% |
| Q1 2019 | -11.10% |
| Q4 2018 | -7.69% |
| Q3 2018 | -7.59% |
| Q2 2018 | -4.43% |
| Q1 2018 | -10.64% |
| Q4 2017 | -8.92% |
| Q3 2017 | -3.76% |
| Q2 2017 | 2669.48% |
| Q1 2017 | -137.94% |
| Q4 2016 | -60.69% |
| Q3 2016 | 65.55% |
| Q2 2016 | -58.47% |
| Q1 2016 | -52.14% |